To compare the efficacy and safety of TCZ in monotherapy (TCZ
Multicenter study of 134 patients with refractory GCA. Patients on TCZ
Patients on TCZ
In clinical practice, TCZ in monotherapy or combined with conventional immunosuppressive agents is effective and safe in patients with GCA. Nevertheless, the addition of immunosuppressive drugs, usually MTX, seems to allow a higher rate of prolonged remission, even in patients with a longer GCA duration, more extra-cranial LVV involvement, and higher acute-phase reactants.